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Abstract
Background: Quantitative PCR (qPCR) is a common method for quantifying mRNA expression. Given the heterogeneity
present in tumor tissues, it is crucial to normalize target mRNA expression data using appropriate reference genes that
are stably expressed under a variety of pathological and experimental conditions. No studies have validated specific
reference genes in canine osteosarcoma (OS). Previous gene expression studies involving canine OS have used one or
two reference genes to normalize gene expression. This study aimed to validate a panel of reference genes commonly
used for normalization of canine OS gene expression data using the geNorm algorithm. qPCR analysis of nine canine
reference genes was performed on 40 snap-frozen primary OS tumors and seven cell lines.
Results: Tumors with a variety of clinical and pathological characteristics were selected. Gene expression stability and
the optimal number of reference genes for gene expression normalization were calculated. RPS5 and HNRNPH were
highly stable among OS cell lines, while RPS5 and RPS19 were the best combination for primary tumors. Pairwise
variation analysis recommended four and two reference genes for optimal normalization of the expression data of
canine OS tumors and cell lines, respectively.
Conclusions: Appropriate combinations of reference genes are recommended to normalize mRNA levels in canine OS
tumors and cell lines to facilitate standardized and reliable quantification of target gene expression, which is essential for
investigating key genes involved in canine OS metastasis and for comparative biomarker discovery.
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Background
Osteosarcoma (OS) is the primary malignant bone tumor
in dogs. Apart from having complex metastatic character-
istics, OS has been observed to have a complex histopath-
ology that develops due to predominantly osteoblastic cell
differentiation as well as a mixture of fibroblastic and
chondroblastic cell differentiation, with varying degrees of
necrosis and tumor matrix present within a tumor [1, 2].
Gene expression studies in canine OS are valuable, as dogs
develop OS spontaneously and have many common
clinical and molecular characteristics that are invaluable
resources for biomarker discovery and offer translational
opportunities [3, 4]. Furthermore, publication of the ca-
nine genome along with the advent of quantitative real-
time PCR (qPCR) and other high-throughput technologies
have enabled studies of key genes involved in OS metasta-
sis and disease progression.
qPCR is a sensitive method for quantifying mRNA
gene transcripts; the two most popular real-time assays
use SYBR® green fluorescent dye and the Taqman® probe.
Many reports have demonstrated the importance of
studying gene expression at the mRNA transcription
level using snap-frozen tissues, micro-dissected tumors
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from paraffin-embedded blocks [5], cellular content from
fine needle aspirates of primary tumors, and various cell
culture models. The quantification of gene expression using
the qPCR method requires appropriate standardization
from initial tissue sampling, RNA extraction protocols,
cDNA synthesis, assay characteristics, and reference gene
validation [6, 7]. Furthermore, it is important to incorporate
internal standards such as reference genes to normalize
mRNA expression levels between different samples to
precisely compare mRNA transcription levels. Ideally, a
reference gene should be stably expressed in tissues or
cells regardless of the histology, pathological condition,
or cellular physiological-metabolic state.
Reference gene expression validation studies have been
conducted in several types of normal, diseased, and
tumor canine tissues [8, 9]. These studies suggested that
stably expressed genes can differ according to the tissue
origin and disease condition, particularly in cancer. Most
gene expression studies examining canine OS have in-
cluded one or two reference genes as the internal control
for data normalization [4, 10–14]. Given the biological
and pathological diversity of OS tumors, it is crucial to
determine the stability of reference genes and their
suitability for normalization to accurately quantify gene
expression data. Thus, in the present study, the mRNA
expression of nine commonly used canine reference
genes was quantified using the SYBR® green fluorescent
dye qPCR assay with canine OS snap-frozen tissues and
cell lines. The geNorm algorithm approach was utilized
to determine the reference gene(s) showing stable expres-
sion for normalization of canine OS mRNA expression
data.
Methods
All procedures were approved by the University of Utrecht,
Netherlands ethical committee, as required under Dutch
legislation. Naturally developed bone tumors were ob-
tained from privately owned euthanized animals or
obtained through a routine medical treatment for can-
cer (surgical resection of tumors) at the Department of
Clinical Sciences of Companion Animals (University Clinic
for Companion Animals) in Utrecht, The Netherlands. No
experimental animals were used for the sole purpose of this
study.
Tissue specimens and clinical-pathological data
Of the dogs with OS clinically diagnosed at the University
Clinic for Companion Animals in Utrecht, The Netherlands,
40 with histologically confirmed primary tumors were
selected for this study. Tissues from these samples
were harvested under sterile conditions during surgery
(amputation/marginal resection/total resection), snap-
frozen in liquid nitrogen, and stored at −70 °C. Histo-
pathology diagnosis and grading [2] were performed
by a certified veterinary pathologist. These 40 tumors
were selected after screening from 60 OS tumors ran-
domly selected from the snap-frozen tumor archive at
the Department of Clinical Sciences of Companion
Animals, University of Utrecht; first based on RNA
quantity (minimum 100 ng/μL in 30 μL) and followed
by RNA quality (RIN > 6.5). The samples that didn’t
qualify these two stages of screening were not included in
this study. The medical records of the selected 40 tumors
were reviewed retrospectively.
Cell lines and culture conditions
Seven well-characterized canine OS cell lines were used
in this study. The cell lines COS31 [15], HMPOS [16],
and POS [17] were obtained through a collaboration
with the University of Florida, USA; KOS-001, KOS-002,
KOS-003 and KOS-004 were kindly gifted by the National
Cancer Institute, NIH, Bethesda, MD, USA. All cell lines
tested negative for mycoplasma using a myco-sensor
qPCR assay kit according to the manufacturer’s protocol
(Agilent Technologies, CA, USA). Cells were maintained
in a sub-confluent monolayer in DMEM supplemented
with 10% fetal bovine serum (Invitrogen, CA, USA) at
37 °C in a humidified atmosphere with 5% CO2.
RNA isolation and cDNA synthesis
RNA in snap-frozen OS tumor materials was isolated as
described previously [3, 18]. Briefly, frozen bone tumor
materials were ground to form bone powder, which was
subjected to RNA isolation protocols. For cells grown in
culture, 1 mL of RLT lysis buffer (Qiagen, Germany) was
used to lyse 75–90% confluent cells grown in 75 mL
flasks, following a single wash of the cells with Hank’s
Balance Salt Solution (PAA Laboratories, GmbH, UK).
These three samples were collected from three independ-
ent passages in culture. RNA was isolated and cDNA syn-
thesis done independently for the three samples and not
pooled together. The three samples were considered as
three independent biological replicates from each cell line.
In addition to that, for qPCR assay, each of these bio-
logical replicate was assessed for gene expression in du-
plicate (technical replicate) using qPCR assays. RNA
isolation and purification was performed using the RNeasy
mini kit according to the manufacturer’s protocol (Qia-
gen). The RNA samples were treated with the Qiagen
RNase-free DNase kit (DNase-I) and eluted in purified
water. Total RNA was quantified using the Nanodrop
ND-1000 spectrophotometer (Isogen Lifesciences, The
Netherlands). RNA quality was evaluated using the Agi-
lent 2100 Bioanalyzer (Agilent Technologies). The cDNA
was synthesized using 0.5 μg total RNA into a total reac-
tion volume of 20 μL from each sample using the iScript
kit cDNA Synthesis Kit according to the manufacturer’s
protocol (Bio-Rad, CA, USA).
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Quantitative real-time PCR
Primers were designed and qPCR products were sequenced
for specificity as previously described [19, 20]. cDNA
samples from both cell lines and tumors were diluted
by two-fold, pooled, and diluted with purified water in
a four-fold serial dilution to assess the amplification ef-
ficiency of each gene. The remaining cDNA samples
were diluted by two-fold and 2 μL was used as a tem-
plate to measure the gene expression in technical dupli-
cates. qPCR was conducted on separate plates for the
OS cell lines from the primary tumors using the SYBR®
green fluorescent dye method. Initial screening for gen-
omic DNA contamination was performed on all sam-
ples using a non-reversed-transcribed RNA template.
qPCR was performed on a MyiQ™ quantitative real-time
PCR machine (Bio-Rad). Reactions were conducted in
duplicate, involving two-step reaction protocols, except
for HPRT which involved a three-step reaction proto-
col, for up to 40 qPCR cycles [19, 20].
Data analysis
Individual reaction data were corrected for qPCR efficien-
cies and analyzed using IQ5 software (Bio-Rad). A box-
plot was generated from the absolute qPCR cycle thresh-
old (Cq) values [6] referring to the RNA transcription of
the tested reference genes in OS tissues and cell lines
using the statistical software SPSS version 16.0 (SPSS, Inc.,
Chicago, IL, USA). Cases with values between 1.5 and 3.0
box length, from the upper or lower edges of the box, are
presented as outliers and indicated by a dark dot. The ex-
pression stability of each reference gene in tumors and cell
lines was calculated independently, and their average
values were recalculated using step-wise exclusion and
pairwise variation analyses, all of which were analyzed
using geNorm (version 3.5) software [21]. GeNorm calcu-
lates the stability of expression (M) of one gene based on
the average pairwise variation between all studied refer-
ence genes. The pairwise variation (V) value illustrates the
variation generated by incorporating various numbers of
reference genes for normalization based on individual
absolute (M) values. A lower V value indicates lower
variation between the selected combinations of reference
genes. Stepwise elimination of the least stable gene reveals
the two most stable genes.
Results
Canine OS samples and reference gene selection
Clinical and pathological data of 40 primary canine OS
tissues from differently sized (medium to large) breeds
used in this study are summarized in Table 1. The tissues
were obtained upon amputation or tumor resection prior
to the initiation of chemotherapy. These tumors consisted
of mixed histopathology characteristics. Seven canine
OS cell lines with varying characteristics, including
morphology, cell proliferation, colony-forming abilities,
migration, and apoptotic rates, were selected. Sub-confluent
cells from 3 independent passages were lysed for RNA
isolation, as representatives for biological replicates
from each cell line. The reference genes selected for
this study were previously described (e.g. RPS19, HPRT,
GAPDH) [3, 18] and several putative reference genes that
have not been used in OS studies, but were expressed in
other canine tissues (e.g. SRPR, HNRNPH, GUSB, RPL8,
RPS5, B2M) [19, 20]. These genes represent different
functional groups, thus avoiding having a cluster of genes
co-regulated in a specific cellular mechanism (Table 2).
Pre-qPCR quality control measures and qPCR efficiencies
RNA quantity in tumors ranged from 173.0 to 2399.3 ng/
μL, while the RNA quality of all samples was acceptable
with a 260/280 ratio of 1.97–2.11. RNA integrity number
Table 1 Characteristics of canine OS tissues (n = 40) used for
this study
Parameter n %
Histological subtypea
OB + FB 12 30
OB + TL 5 12.5
OB + CB + FB 7 17.5
OB + FB + TL 2 5
OB 14 35
Histological grade
High 28 70
Medium-low 12 30
Necrosis
< 50% (low) 12 30
> 50% (high) 28 70
Sex
Female 14 35
Male 26 65
Neuter status
Intact 22 55
Neutered 18 45
Location of primary tumor
Extraskeletal 1 2.5
Femur 1 2.5
Humerus 8 20
Mandible/maxilla 3 7.5
Radius/ulna 14 35
Rib 2 5
Scapula 3 7.5
Tibia/fibula/metatarsus 8 20
aCB chondroblastic, FB fibroblastic, OB osteoblastic, TL telangiectic
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(RIN) values were 9.5–10.0 for the cell lines and above 6.5
for the snap-frozen tumors. Primer sequences, product
size, and optimal annealing temperature for each reference
gene were previously verified [19, 20] and are summarized
in Table 3. qPCR was performed in duplicate for each
sample in which separate assays for cell lines and tumors
were performed. Both the non-reverse transcribed tem-
plate control samples were below the detection limits in
every qPCR. qPCR efficiencies were between 91.1% and
103.1% for the cell lines and between 94.9% and 104.1%
for the tumors. All qPCRs exhibited a single melting curve
representing a specific product.
Reference gene expression variation in OS tumors and
cell lines
Reference genes that were highly expressed in both OS
tumors and cell lines, based on average Cq values, were
GAPDH, followed by the ribosomal RNA genes RPS19,
RPS5, and RPL8. SRPR showed the lowest expression.
Although the absolute Cq range differed slightly between
the tumor and cell line assays, a coherent expression
pattern was observed. The expression range and average
Cq values for each reference gene in OS tumors and cell
lines are shown in Fig. 1.
Expression stability of reference genes in canine OS
tumors and cell lines
The average reference gene expression stability (M
value) upon step-wise exclusion and pairwise variation
(V value) were calculated using the geNorm algorithm
approach for the tumors and cell lines individually. A
higher absolute M value indicates lower expression stability
and vice versa (Table 4). Among the reference genes tested
for the canine OS cell lines, HNRNPH was the most stable
gene with an M value of 0.420, while SRPR appeared to be
the least stably expressed gene with an M value of 0.588, al-
though all reference genes had acceptable M values. For OS
tumors, absolute M values ranged from 0.790 for RPS19
(most stable) to 1.210 for B2M (least stable) compared to
the other reference genes. The average expression stabilities
Table 2 Reference genes for canine OS and their cellular function(s)
Gene symbol Name Function
RPS5 Ribosomal protein S5 Ribosomal protein that is a component of the 40S subunit, belongs to the S7P
family of ribosomal proteins
RPS19 Ribosomal protein S19 Ribosomal protein that is a component of the 40S subunit, belongs to the S19E
family of ribosomal proteins
HPRT Hypoxanthine guanine phosphoribosyl
transferase
Purine metabolism, salvage of purines from degraded RNA
HNRNPH Heterogeneous nuclear ribonucleoprotein H RNA-binding protein that forms a complex with heterogeneous nuclear RNA (hnRNA).
These proteins are associated with pre-mRNAs in the nucleus and appear to influence
pre-mRNA processing and other aspects of mRNA metabolism and transport
RPL8 Ribosomal protein L8 Ribosomal protein that is a component of the 60S subunit which catalyzes protein
synthesis
GAPDH Glyceraldehyde-3-phosphate dehydrogenase Enzyme in glycolysis and gluconeogenesis pathway
B2M β-2-Microglobulin Beta chain of MHC class I molecules
SRPR Signal recognition particle receptor Ensures, in conjunction with the signal recognition particle, the correct targeting of the
nascent secretory proteins to the endoplasmic reticulum membrane system
GUSB β-glucuronidase Role in degradation of dermatan and keratin sulphates
Table 3 Details of primers and qPCR conditions for the putative reference genes assessed in this study
Reference gene Accession number Forward primer 5′ to 3′ Reverse primer 5′ to 3′ Product length (bp) Ta (°C)
RPS5 XM_533568 TCACTGGTGAGAACCCCCT CCTGATTCACACGGCGTAG 141 62.5
RPS19 XM_533657 CCTTCCTCAAAAAGTCTGGG GTTCTCATCGTAGGGAGCAAG 95 61
HPRT AY_283372 AGCTTGCTGGTGAAAAGGAC TTATAGTCAAGGGCATATCC 114 56
HNRNPH XM_53857 CTCACTATGATCCACCACG TAGCCTCCATAACCTCCAC 151 61.2
RPL8 XM_532360 CCATGAATCCTGTGGAGC GTAGAGGGTTTGCCGATG 64 55
GAPDH NM_001003142 TGTCCCCACCCCCAATGTATC CTCCGATGCCTGCTTCACTACCTT 100 58
B2M XM_535458 TCCTCATCCTCCTCGCT TTCTCTGCTGGGTGTCG 85 61.2
SRPR XM_03184 GCTTCAGGATCTGGACTGC GTTCCCTTGGTAGCACTGG 81 61.2
GUSB NM_001003191 AGACGTTCCAAGTACCCC AGGTGTGGTGTAGAGGAGCAC 103 62
Ta annealing temperature, bp base pair
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of the 9 tested reference genes among cell lines and tu-
mors upon the stepwise exclusion algorithm are depicted
in Fig. 2. HNRNPH and RPS5 expression, together, showed
the lowest variability for the cell lines, while RPS19 and
RPS5 were the best combination for the tumors.
Pairwise variation (V value), which reflects the optimal
number of reference genes for normalization in tumors
and cell lines, was also calculated. A lower the V value
indicates lower variation between the selected combina-
tions of reference genes. Normalization of gene expres-
sion data among 40 OS tumors required a minimum
combination of 3 (V value is 0.15) and optimally 4 refer-
ence genes (V value <0.15), while a combination of 2 ref-
erence genes was sufficient for the OS cell lines (Fig. 3).
These values were determined according to a cut-off V
value of 0.15 as per published recommendations [21].
Discussion
Selection of suitable reference genes is crucial for accur-
ate interpretation of gene expression data [21, 22]. Many
quality control measures, from initial sample collection
to data analysis, should be evaluated critically prior to
analysis of gene expression data [23, 24]. Reference
genes, previously known as ‘housekeeping genes,’ are es-
sential not only for normalizing the mRNA expression
of target genes, but also for correcting variations in ini-
tial RNA sample input, extraction methods, and reaction
efficiencies [25]. Failure to normalize gene expression
data may result in inaccurate interpretation and promote
false perception of target gene expression.
Numerous studies have been conducted to validate
panels of reference genes in different tissues from differ-
ent animals [26–29], including dogs. Previous studies on
reference gene analysis using the GeNorm approach was
done on soft tissues from dogs including skin, prostate,
kidney, mammary gland, heart and liver tissues [19, 20].
Bone tissues are of mesenchymal origin and certainly
have a set of genes expressed differentially compared to
soft tissues. It is not known if the optimal reference
genes would be the same as other soft tissues, hence this
study was necessary. Besides that, there are only two other
studies on reference genes on tumor specimens using the
GeNorm analysis which are on canine soft tissue sarcoma
(n = 6 tumors) [30] and canine mammary gland tumors
(n = 22 tumors) [9]. Reference genes stably expressed in
canine soft tissue sarcoma are β-Glucuronidase (GUSB)
and proteasome subunit, beta type, 6 (PSMB6); while in
canine mammary gland tumors were a combination of
hypoxanthine-phosphoribosyl transferase, ATP-synthase
subunit 5B, ribosomal protein L32 and ubiquitin. These
two studies suggest different set of reference gene which
are stably expressed as compared to the current study on
canine osteosarcoma.
This study investigated the reliability of several refer-
ence genes expression in snap-frozen tumors and in cell
lines of canine OS origin. The present study validated a
panel of nine reference genes commonly used for qPCR
investigations on dog tissues. Although this is not the
first study to demonstrate the need for reference gene
Fig. 1 Box-plots demonstrating the absolute Cq values, 25%/75% percentiles, and outliers (indicated by dark dots) for mRNA transcription
quantified for the putative reference genes in: a canine OS snap-frozen primary tumors and b for canine OS cell lines
Table 4 Reference genes ranked based on their expression
stability, M, in canine osteosarcoma primary tumors and cell lines
Primary tumors (tissues) Cell lines
Gene M value Gene M value
RPS19 0.790 HNRNPH 0.420
RPS5 0.796 RPS5 0.423
HNRNPH 0.803 B2M 0.475
HPRT 0.808 RPS19 0.494
GUSB 0.816 GUSB 0.508
GAPDH 0.835 HPRT 0.510
RPL8 0.842 GAPDH 0.510
SRPR 0.921 RPL8 0.579
B2M 1.210 SRPR 0.588
The lower the M value for a gene, the more stable expression is across
the samples
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validation in tumor tissues from dogs, this is the first
study to use OS tissues and to incorporate the largest
number of snap-frozen canine tumor tissues and cell
lines in a single canine reference gene validation study.
The popular and established statistical tool geNorm (ver-
sion 3.5) was used to calculate reference gene expression
stability. For technical considerations, most ‘essential’
criteria outlined in the MIQE (Minimum Information
for Publication of Quantitative Real-Time PCR Experi-
ments) standards were employed in the current investi-
gation in canine OS tissues [6]. The present study was
unable to examine gene expression for biological repli-
cates of OS tumors as recommended in the MIQE
guidelines and power analysis was not conducted prior
to the experiment to determine the number of samples
necessary for valid conclusions, as the samples were ob-
tained from naturally developed tumors in dogs and not
from an experimental laboratory setting where the
sample size can be controlled. The sample size in this
study was based on sample availability, and with good
quality RNA and sufficient RNA (quantity).
All nine reference genes tested in both canine OS
snap-frozen tumors and cell lines showed acceptable ex-
pression stability with M values below 1.5. Overall, refer-
ence genes were much more stably expressed in cell
lines (M values of 0.420–0.588) compared to those in
tumor tissues (M values of 0.790–1.210), clearly indicating
homogeneity among cell populations in cultured systems.
In contrast, tumor tissues contain more heterogeneous
cell populations.
Ribosomal protein genes (components of both 40S
and 60S subunits) are highly expressed in various tissues
and are preferred references for normalization in various
models [8, 19, 20, 29], including in the present study of
canine OS. Although there were slight differences in the
ranking of genes (according to absolute M values) between
those tested for the cell lines and tumors, RPS5 was the
most stable gene in both model systems. RPS5 in combin-
ation with RPS19 (for tumor tissues) or HNRNPH (for cell
lines) showed the highest expression stability compared
to other genes such as B2M and GAPDH, which are the
most commonly used reference genes in many human
Fig. 2 Expression plots generated by geNorm for a canine OS primary
tumors and b canine OS cell lines for the average expression stability
(M values) for the 9 tested genes upon step-wise exclusion method.
Less stable genes were eliminated by the step-wise exclusion method
and the average M value was re-calculated among the remaining
candidate genes. The 2 most stable genes for OS primary tumors
were RPS5 and HNRNPH, while RPS5 with RPS19 were the most
stable combination among cell lines
Fig. 3 Pairwise variation plots for the 9 reference genes revealed the
minimum number of reference genes required for normalization in:
a canine OS primary tumors (minimum 4 genes) and b canine OS
cell lines (minimum 2 genes)
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and canine OS studies to date [10, 18, 31]. GAPDH ex-
pression did not appear to differ remarkably between
OS samples, but its expression stability was much lower
than the other reference genes investigated in the present
study, which agrees with several previous reports [32, 33].
GAPDH is an enzyme involved in several metabolic path-
ways that are essential for cell growth and proliferation,
and its expression has shown to differ in different tissue
types and environment conditions [22, 34]. In an investi-
gation of canine articular connective tissue, GAPDH and
B2M were found to be highly stable [35], while in canine
mammary tumors, GAPDH was less stable [9]. Further-
more, GAPDH protein expression in cultured cells may
change depending upon cell density [34], and it was also
found to be differentially expressed between tumors of
epithelial origin and their normal counterparts [22].
Among canine OS tumors, B2M showed the lowest ex-
pression stability compared to the other eight candidate
genes investigated in this study. Therefore, it is not rec-
ommended to rely on B2M nor GAPDH as a sole refer-
ence gene to normalize gene expression data.
Pairwise analysis of a combination of genes that can be
used for normalization revealed that four reference genes
for canine OS tumors and two for the cell lines were es-
sential based on a recommended cut-off point. A lower V
indicated smaller variation, suggesting that adding an add-
itional gene did not significantly improve normalization.
A cut-off value of 0.15 for pairwise variation is commonly
used, indicating that the use of a set of reference genes
with a pairwise variation results in valid normalization.
As more genes are incorporated for normalization, the
V value decreases to an optimal seven reference genes,
which can be considered during normalization, given
the expression data across canine OS tumors. When
sample availability and RNA yield is limited, particularly
from OS tumor materials, a minimum of three reference
genes is acceptable, and four reference genes are optimal
for normalization. OS typically shows a complex heteroge-
neous phenotype, and thus we recommend including mul-
tiple reference genes for the normalization of mRNA gene
expression data.
The current study incorporated canine OS tumors,
which are chemo-naive, and thus we cannot exclude the
possibility of changes in reference gene stability in tumors
induced by the various therapeutic modalities employed
in clinical and experimental settings. If gene expression
quantification comparing the effects of a given therapy is
required, screening of a panel of reference genes may be
essential prior to data normalization. Additionally, based
on the assumption that RNA isolated from a specific tis-
sue section represents the overall pooled expression in the
tumor, RNA transcription in canine OS tumor tissues was
quantified from a single tissue section from an individual
OS tumor. Several other studies have recommended
incorporating different parts of the same tumor to include
separate biological replicates to more accurately quantify
gene expression. However, this is often not feasible be-
cause of limited tissue availability. Further studies are ne-
cessary to test other potential or novel reference genes
identified by global gene expression profiling methods and
subsequently validated using other statistical algorithms.
Because canine spontaneous OS is a clinically and bio-
logically relevant model for human OS [36], we propose
that multiple reference genes should be included in future
normalization of gene expression data for both species to
improve the accuracy and reliability of gene expression
quantification.
Conclusions
In conclusion, this study agreed with the consensus opin-
ion that no single reference gene can accurately normalize
given expression data. A combination of reference genes is
recommended for normalizing the gene expression data
from OS tumors and cell lines, with a preference for RPS5
as a highly stable reference gene in canine OS.
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